6-substituted indole-3-carboxylic acid amide compounds having sphingosine1-phosphate (S1P) receptor antagonist biological activity

Details for Australian Patent Application No. 2008347006 (hide)

Owner Allergan, Inc.

Inventors Yuan, Haiqing; Beard, Richard L.; Donello, John E.; Liu, Xiaoxia; Duong, Tien T.

Agent Davies Collison Cave

Pub. Number AU-A-2008347006

PCT Pub. Number WO2009/088531

Priority PCT/ US2008/050695 10.01.08 US; 12/013,239 11.01.08 US

Filing date 10 July 2008

Wipo publication date 16 July 2009

International Classifications

C07D 209/42 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/404 (2006.01)

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

5 August 2010 PCT application entered the National Phase

  PCT publication WO2009/088531 Priority application(s): WO2009/088531

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008347012-Pour channel with cohesive closure valve and locking bubble

2008347005-Pterin analog for treating BH4 responsive condition